Medherant

Medherant
Medherant
Medherant is a clinical stage drug delivery company developing products for pain and CNS diseases. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. Medherant has developed a novel drug-in-adhesive transdermal delivery system, the TEPI® Patch, using a proprietary adhesive which it has exclusively licensed from Bostik.
Coventry
Pharmaceuticals, CNS diseases, eHealth, Healthcare
2015
www.medherant.co.uk

Articles about Medherant:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Medherant? We’re happy to assist you with our Startup Sourcing service.